Published in Semin Neonatol on February 01, 2002
The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol (2012) 1.93
Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS One (2010) 1.42
Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs (2010) 1.37
Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice. Proc Natl Acad Sci U S A (2004) 1.33
Lysosomal storage disorders in the newborn. Pediatrics (2009) 1.29
Increased activity and altered subcellular distribution of lysosomal enzymes determine neuronal vulnerability in Niemann-Pick type C1-deficient mice. Am J Pathol (2009) 1.12
Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB. PLoS One (2012) 1.08
Sphingolipid lysosomal storage disorders. Nature (2014) 1.08
New strategies for enzyme replacement therapy for lysosomal storage diseases. Rejuvenation Res (2010) 1.00
Assessment of a targeted resequencing assay as a support tool in the diagnosis of lysosomal storage disorders. Orphanet J Rare Dis (2014) 0.97
Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review. Orphanet J Rare Dis (2010) 0.93
Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker. J Clin Invest (2014) 0.92
Lysosomal storage disorders: molecular basis and laboratory testing. Hum Genomics (2011) 0.90
Neural stem cell transplantation benefits a monogenic neurometabolic disorder during the symptomatic phase of disease. Stem Cells (2009) 0.86
Perinatal gene transfer to the liver. Curr Pharm Des (2011) 0.84
Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature. Orphanet J Rare Dis (2012) 0.82
Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI. J Pediatr Rehabil Med (2014) 0.81
Clinical aspects of neuropathic lysosomal storage disorders. J Inherit Metab Dis (2010) 0.81
Diagnosis of inherited disorders of liver metabolism. J Inherit Metab Dis (2003) 0.78
Up-regulation of cation-independent mannose 6-phosphate receptor and endosomal-lysosomal markers in surviving neurons after 192-IgG-saporin administrations into the adult rat brain. Am J Pathol (2006) 0.78
Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery. Int J Cell Biol (2015) 0.76
Quality of life of brazilian patients with Gaucher disease and fabry disease. JIMD Rep (2012) 0.76
Selective screening for lysosomal storage diseases with dried blood spots collected on filter paper in 4,700 high-risk colombian subjects. JIMD Rep (2013) 0.76
Invertebrate models of lysosomal storage disease: what have we learned so far? Invert Neurosci (2011) 0.76
Spectrum of paediatric lysosomal storage disorders in oman. Sultan Qaboos Univ Med J (2012) 0.76
Anterior segment OCT imaging in mucopolysaccharidoses type I, II, and VI. Eye (Lond) (2014) 0.75
The crucial impact of lysosomes in aging and longevity. Ageing Res Rev (2016) 0.75
Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry. Orphanet J Rare Dis (2014) 0.75
Clinical neurogenetics: neuropathic lysosomal storage disorders. Neurol Clin (2013) 0.75
Evaluation of transduction properties of an adenovirus vector in neonatal mice. Biomed Res Int (2015) 0.75